Physician
Jonathan A. Feistmann, MD PC
Jonathan A. Feistmann, MD PC was paid $3.99M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 25% of everything it billed.
33Billing provider infoJONATHAN A. FEISTMANN, MD PC
NEW YORK, NY 10003
NEW YORK, NY 10003
33aNPI1619112943assigned 12/16/2008
33bProvider typeOphthalmology Physician
28Total paid$3.99M
24GClaims37,227
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#24 of 1,085
Median peer was paid$34K
This provider vs. median118×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,113 | $70K | |
| 2019 | 3,563 | $198K | |
| 2020 | 4,080 | $543K | |
| 2021 | 6,689 | $671K | |
| 2022 | 7,812 | $714K | |
| 2023 | 8,789 | $1.17M | |
| 2024incomplete | 5,181 | $620K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 25% | 688 | 558 | $982K |
| 67228 | 11% | 1,449 | 1,071 | $436K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 10% | 4,284 | 4,182 | $408K |
| 67028 | Intravitreal injection of a pharmacologic agent | 10% | 4,230 | 3,399 | $403K |
| 92134 | 10% | 10,935 | 10,418 | $400K | |
| 67210 | 8.6% | 763 | 685 | $342K | |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4.4% | 119 | 96 | $177K |
| 92235 | 3.6% | 1,242 | 1,241 | $143K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 826 | 826 | $137K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.1% | 1,468 | 1,402 | $122K |
| J9035 | Injection, bevacizumab, 10 mg | 3.0% | 1,945 | 1,610 | $121K |
| 92250 | 2.5% | 2,513 | 2,355 | $100K |
10 more codes
| 92273 | 1.9% | 751 | $74K | |
| 92202 | 1.0% | 3,304 | $41K | |
| 92226 | <1% | 1,138 | $32K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 240 | $31K |
| 92225 | <1% | 490 | $15K | |
| 92201 | <1% | 651 | $14K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 63 | $5K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 29 | $3K |
| 76512 | <1% | 66 | $3K | |
| 99024 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFEISTMANN, JONATHAN (PRESIDENT)